Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Relmada Therapeutics (RLMD) Other Operating Expenses (2022)

Relmada Therapeutics has reported Other Operating Expenses over the past 2 years, most recently at $723.0 for Q1 2013.

  • Quarterly Other Operating Expenses changed N/A to $723.0 in Q1 2013 from the year-ago period, while the trailing twelve-month figure was $723.0 through Nov 2013, changed N/A year-over-year, with the annual reading at $6.4 million for FY2022, N/A changed from the prior year.
  • Other Operating Expenses was $723.0 for Q1 2013 at Relmada Therapeutics, up from $309.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1048.0 in Q3 2012 and troughed at $309.0 in Q4 2012.